Biogen Message Board - Msg: 227894

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 179.97

+2.2%

Jan 30 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Harold Engstrom who wrote ()	8/17/1996 5:20:00 PM
From: Michael H. Dragon	of 1686

Harold, Biogen has been a core holding of mine for 5 years now and I bought and sold positions in it over and over, always maintaining a position in the stock though.Presently it is my largest position and I think that it doesn't get the true value of the company priced into it's stock price.Their science is among the best.Schering Plough's biggest product,Intron A is from Biogen and royalties are paid to biogen plus all of the royalties paid to biogen from hepatitis B vaccines. I read and article where they said that for every 100 million in sales of Avonex, Biogen can expect to earn $1.00/share.I think that after the European approvals come through in several years time Biogen could be earning $7-$8/share.As far as competing drugs go the only one that I think could hurt Biogen is if Autoimmune's drug for MS proves effective. They are trying to develop a drug to be taken orally.I think they are suppose to unmask trial results in December but I'm not sure.If they don't prove safe and effective I think a major Pharmaceutical company will make an offer on Biogen.I'm also excited about the collaborative agreement signed with Ontogeny.I'm glad you started this thread, I've thought about it several times. Mike D. / ,

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext